CLINICAL_TRIALS
trial_result
· 2024-11-12
Clinical Trial Update: A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients [Phase 1]
Summary
Phase 1 clinical trial evaluating whether troxerutin can prevent thrombotic events in patients with COVID-19-associated coagulopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Westlake University | Conditions: COVID 19 Associated Coagulopathy | Phase 1 | Status: RECRUITING